Literature DB >> 10498166

Prescription medications: a modifiable contributor to obesity.

L J Cheskin1, S J Bartlett, R Zayas, C H Twilley, D B Allison, C Contoreggi.   

Abstract

BACKGROUND: While usually not the only factor in obese patients, prescription medications, which may increase appetite or body weight, can be important in some individuals. The cause of weight gain in such cases may go unrecognized or lead to cessation of medication with or without the practitioner's knowledge or approval.
METHODS: We found illustrative cases among patients treated at the Johns Hopkins Weight Management Center, searched MEDLINE and the Micromedex Drug Information database, and organized this information by drug mechanism and indications for use.
RESULTS: Most reports of medication-induced weight gain are anecdotal or gleaned from clinical trials. Notable offenders include hormones (especially corticosteroids and insulinotropic agents), and psychoactive medications (especially tricyclic antidepressants, lithium, and some antipsychotics).
CONCLUSIONS: Medication-related increases in appetite and body weight are under-recognized and cause noncompliance with pharmacotherapy. A high index of awareness of the known mechanisms by which medications can lead to weight gain has the potential to prevent most medication-related contributions to weight gain and obesity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10498166     DOI: 10.1097/00007611-199909000-00009

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  11 in total

1.  Factors influencing cardiovascular risk following termination of glucocorticoid therapy for nephrotic syndrome.

Authors:  Akio Nakamura; Ryo Niimi; Kumiko Kurosaki; Yukishige Yanagawa
Journal:  Clin Exp Nephrol       Date:  2010-07-17       Impact factor: 2.801

Review 2.  Common Medications Which Lead to Unintended Alterations in Weight Gain or Organ Lipotoxicity.

Authors:  Valentina Medici; Stephen A McClave; Keith R Miller
Journal:  Curr Gastroenterol Rep       Date:  2016-01

3.  Higher Dietary Choline and Betaine Intakes Are Associated with Better Body Composition in the Adult Population of Newfoundland, Canada.

Authors:  Xiang Gao; Yongbo Wang; Edward Randell; Pardis Pedram; Yanqing Yi; Wayne Gulliver; Guang Sun
Journal:  PLoS One       Date:  2016-05-11       Impact factor: 3.240

4.  Higher serum choline and betaine levels are associated with better body composition in male but not female population.

Authors:  Xiang Gao; Edward Randell; Haicheng Zhou; Guang Sun
Journal:  PLoS One       Date:  2018-02-20       Impact factor: 3.240

5.  Metabolomics Based Profiling of Dexamethasone Side Effects in Rats.

Authors:  Abeer K Malkawi; Karem H Alzoubi; Minnie Jacob; Goran Matic; Asmaa Ali; Achraf Al Faraj; Falah Almuhanna; Majed Dasouki; Anas M Abdel Rahman
Journal:  Front Pharmacol       Date:  2018-02-16       Impact factor: 5.810

Review 6.  Medications that cause weight gain and alternatives in Canada: a narrative review.

Authors:  Sean Wharton; Lilian Raiber; Kristin J Serodio; Jasmine Lee; Rebecca Ag Christensen
Journal:  Diabetes Metab Syndr Obes       Date:  2018-08-21       Impact factor: 3.168

7.  Clinician uptake of obesity-related drug information: a qualitative assessment using continuing medical education activities.

Authors:  Ingrid Kohlstadt; Gerold Wharton
Journal:  Nutr J       Date:  2013-04-10       Impact factor: 3.271

8.  Weight change in diabetes and glycemic and blood pressure control.

Authors:  Adrianne C Feldstein; Gregory A Nichols; David H Smith; Victor J Stevens; Keith Bachman; A Gabriela Rosales; Nancy Perrin
Journal:  Diabetes Care       Date:  2008-06-20       Impact factor: 17.152

Review 9.  Overweight and obesity in children and adolescents.

Authors:  Neslihan Koyuncuoğlu Güngör
Journal:  J Clin Res Pediatr Endocrinol       Date:  2014-09

10.  The association between diet and glucocorticoid treatment in patients with SLE.

Authors:  Cecilia Lourdudoss; Ingiäld Hafström; Johan Frostegård; Ronald van Vollenhoven
Journal:  Lupus Sci Med       Date:  2016-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.